Sign in
Not yet taking people in United StatesNo phase

BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
270 people, planned
Started
1 Jul 2026
Expected to end
31 Dec 2035
Type of study
Observational
Treatments tested
  • Blood Sample Collection
Record updated
9 June 2026

Who can take part

Age
16 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age: Subjects aged 16 years and older
  • Injury Type/Evidence: Patients with a confirmed PBI as demonstrated by head imaging or physical exam (evidence of dural penetration by a projectile)
  • Timeframe: Patients must be enrolled within 8 hours of injury

Who cannot take part

  • No subjects will be excluded based on gender or ethnicity for this study. Subjects under the age of 16 will be excluded. These subjects differ significantly in terms of neurodevelopment, physiology, and trauma response, which introduces heterogeneity that could confound study results. Additionally, pediatric PBI has distinct etiologies, treatment pathways, and prognostic indicators compared to adult PBI (note that age 16 and up are treated medically as adults)
  • FULL EXCLUSION CRITERIA:
  • Dead on Arrival (DOA): Patients who receive CPR with no return of pulse
  • Non-penetrating injury: Patients with head injuries that do not include dural penetration
  • Polytrauma: Patients with penetrating or blunt injuries to other parts of the body
  • Known or suspected pregnancy
  • Known or suspected prisoner

Where in United States

  • The University Of ChicagoChicago, United StatesContact: Hugh FlynnNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specific to PBI is extremely limited, and could provide critical insight to outcome identification and clinical decision making.

Read full original descriptionShow less

This data will be used to build the first comprehensive PBI Data Commons, biorepository, and imaging repository which will create the infrastructure necessary to close critical knowledge gaps, advance biomarker discovery specific to PBI, and provide the foundation for future research aimed at improving prognostication and treatment for patients with this devastating injury.

Treatments tested

  • Blood Sample Collection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 June 2026